OncoGenex Technology Patents. Subject to 8.3.1(e) OncoGenex will have the sole right, but not the obligation, at its own expense, to remove infringement of OncoGenex Technology Patents using commercially appropriate steps, including the filing of an infringement suit or taking other similar action, and Isis will have the right, at its own expense, to be represented in any such action.
Appears in 2 contracts
Sources: License Agreement (Oncogenex Pharmaceuticals, Inc.), License Agreement (Oncogenex Pharmaceuticals, Inc.)